ISC 2023 | Gathering high-level evidence for thrombectomy in pediatric stroke

Kartik Bhatia, MBBS, PhD, Sydney Children’s Hospital Network, University of Sydney, Westmead, Australia, highlights ongoing efforts to drive progress in pediatric stroke management. Obtaining strong, comparative data on the use of reperfusion therapy is a challenge in this space, given the rarity of pediatric ischemic stroke and the absence of clinical equipoise. The Save ChildS retrospective cohort study is one study that evaluated the use of endovascular recanalization in children, demonstrating a safety and efficacy profile reflective of that in adult patients. The study authors have now set up a prospective, multicenter registry (Save ChildS Pro) to continue investigating safety and outcomes of endovascular therapy, compared to best medical management, in childhood stroke. A similar Australian collaboration is also underway. These studies aim to provide high-level evidence for endovascular therapy in pediatric stroke to improve uptake and thus, improve outcomes and quality of life for patients. This interview took place during the International Stroke Conference (ISC) 2023 in Dallas, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.